Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Biodesix (BDSX) Gross Profit: 2019-2025

Historic Gross Profit for Biodesix (BDSX) over the last 6 years, with Sep 2025 value amounting to $17.7 million.

  • Biodesix's Gross Profit rose 26.41% to $17.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $64.0 million, marking a year-over-year increase of 25.58%. This contributed to the annual value of $55.8 million for FY2024, which is 54.53% up from last year.
  • Biodesix's Gross Profit amounted to $17.7 million in Q3 2025, which was up 10.48% from $16.0 million recorded in Q2 2025.
  • In the past 5 years, Biodesix's Gross Profit registered a high of $17.7 million during Q3 2025, and its lowest value of $3.3 million during Q1 2022.
  • Over the past 3 years, Biodesix's median Gross Profit value was $14.0 million (recorded in 2024), while the average stood at $12.7 million.
  • In the last 5 years, Biodesix's Gross Profit skyrocketed by 202.93% in 2021 and then slumped by 68.89% in 2022.
  • Over the past 5 years, Biodesix's Gross Profit (Quarterly) stood at $4.7 million in 2021, then surged by 33.19% to $6.3 million in 2022, then soared by 79.24% to $11.3 million in 2023, then spiked by 42.44% to $16.1 million in 2024, then increased by 26.41% to $17.7 million in 2025.
  • Its Gross Profit stands at $17.7 million for Q3 2025, versus $16.0 million for Q2 2025 and $14.3 million for Q1 2025.